Sara Baglivo

Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with nivolumab: long-term outcomes from a multi-institutional analysis

Biagio Ricciuti, Carlo Genova, Andrea De Giglio et al. · Journal of Cancer Research and Clinical Oncology · 2018 · 357 citations · Full text

Medicine, Immunology, Multi-institutional Analysis +8

Concomitant TP53 Mutation Confers Worse Prognosis in EGFR-Mutated Non-Small Cell Lung Cancer Patients Treated with TKIs

Matteo Canale, Elisabetta Petracci, Angelo Delmonte et al. · Journal of Clinical Medicine · 2020 · 68 citations · Full text

Kynurenine/Tryptophan Ratio as a Potential Blood-Based Biomarker in Non-Small Cell Lung Cancer

Martina Mandarano, Elena Orecchini, Guido Bellezza et al. · International Journal of Molecular Sciences · 2021 · 57 citations · Full text

Prognostic Role of Circulating miRNAs in Early-Stage Non-Small Cell Lung Cancer

Paola Ulivi, Elisabetta Petracci, Giorgia Marisi et al. · Journal of Clinical Medicine · 2019 · 52 citations · Full text

Immunology, Pathology, Tumor Biology +18

Safety and Efficacy of Nivolumab in Patients With Advanced Non–small-cell Lung Cancer Treated Beyond Progression

Biagio Ricciuti, Carlo Genova, Maria Bassanelli et al. · Clinical Lung Cancer · 2019 · 52 citations

Oncology, Cancer Management, Immune Checkpoint Inhibitor +4